SAB Biotherapeutics reports Q3 results
Source: SeekingAlpha
2025-11-13 17:46:50 ET
More on SAB Biotherapeutics
- Seeking Alpha’s Quant Rating on SAB Biotherapeutics
- Historical earnings data for SAB Biotherapeutics
- Financial information for SAB Biotherapeutics
Read the full article on Seeking Alpha
For further details see:
SAB Biotherapeutics reports Q3 results
SAB Biotherapeutics Inc.
NASDAQ: SABS
SABS Trading
0.66% G/L:
$3.825 Last:
78,735 Volume:
$3.71 Open:
SABS Latest News
January 07, 2026 08:00:00 am
SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director
January 06, 2026 08:00:00 am
SAB BIO to Present at the 44th Annual J.P. Morgan Healthcare Conference
SABS Stock Data
$198,996,637
35,676,574
26.21%
14
N/A
Biotechnology & Life Sciences
Healthcare
US
Miami Beach
